Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Long-Term Deferred Tax (2022 - 2025)

CV Sciences' Long-Term Deferred Tax history spans 4 years, with the latest figure at $13.5 million for Q4 2025.

  • On a quarterly basis, Long-Term Deferred Tax fell 1.28% to $13.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $13.5 million, a 1.28% decrease, with the full-year FY2025 number at $13.5 million, down 1.28% from a year prior.
  • Long-Term Deferred Tax hit $13.5 million in Q4 2025 for CV Sciences, down from $13.7 million in the prior quarter.
  • Over the last five years, Long-Term Deferred Tax for CVSI hit a ceiling of $17.9 million in Q4 2022 and a floor of $13.5 million in Q4 2025.
  • Historically, Long-Term Deferred Tax has averaged $15.6 million across 4 years, with a median of $15.4 million in 2023.
  • Biggest five-year swings in Long-Term Deferred Tax: decreased 20.28% in 2024 and later dropped 1.28% in 2025.
  • Tracing CVSI's Long-Term Deferred Tax over 4 years: stood at $17.9 million in 2022, then dropped by 4.28% to $17.1 million in 2023, then decreased by 20.28% to $13.7 million in 2024, then fell by 1.28% to $13.5 million in 2025.
  • Business Quant data shows Long-Term Deferred Tax for CVSI at $13.5 million in Q4 2025, $13.7 million in Q4 2024, and $17.1 million in Q4 2023.